(4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one

C24H38BrNO3 — CID 11851047

IUPAC(4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one
SMILESC/C(=C\CBr)CC/C=C(\C)CC/C=C(\C)CCCC(=O)N1C(=O)OC[C@H]1C(C)C
InChIInChI=1S/C24H38BrNO3/c1-18(2)22-17-29-24(28)26(22)23(27)14-8-13-20(4)10-6-9-19(3)11-7-12-21(5)15-16-25/h10-11,15,18,22H,6-9,12-14,16-17H2,1-5H3/b19-11+,20-10+,21-15+/t22-/m0/s1
InChIKeyLGFHLJOHIPAVOP-JVRDZCOLSA-N
MW468.48 g/mol
LogP6.95
Rot. Bonds12

About (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one

(4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one (PubChem CID 11851047) has the molecular formula C24H38BrNO3 and a molecular weight of 468.48 g/mol. Its IUPAC name is (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one.

Molecular Properties

Compound Name(4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one
PubChem CID11851047
Molecular FormulaC24H38BrNO3
Molecular Weight468.48 g/mol
Exact Mass467.20
IUPAC Name(4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one
SMILESC/C(=C\CBr)CC/C=C(\C)CC/C=C(\C)CCCC(=O)N1C(=O)OC[C@H]1C(C)C
InChIInChI=1S/C24H38BrNO3/c1-18(2)22-17-29-24(28)26(22)23(27)14-8-13-20(4)10-6-9-19(3)11-7-12-21(5)15-16-25/h10-11,15,18,22H,6-9,12-14,16-17H2,1-5H3/b19-11+,20-10+,21-15+/t22-/m0/s1
InChIKeyLGFHLJOHIPAVOP-JVRDZCOLSA-N
XLogP6.95
TPSA46.61 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds12
Heavy Atoms29
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500468.48
LogP ≤ 56.95
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one?
The IUPAC name of (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one (CID 11851047) is (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one.
What is the SMILES notation for (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one?
The canonical SMILES for (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one is C/C(=C\CBr)CC/C=C(\C)CC/C=C(\C)CCCC(=O)N1C(=O)OC[C@H]1C(C)C.
What is the InChIKey of (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one?
The InChIKey is LGFHLJOHIPAVOP-JVRDZCOLSA-N. The full InChI is InChI=1S/C24H38BrNO3/c1-18(2)22-17-29-24(28)26(22)23(27)14-8-13-20(4)10-6-9-19(3)11-7-12-21(5)15-16-25/h10-11,15,18,22H,6-9,12-14,16-17H2,1-5H3/b19-11+,20-10+,21-15+/t22-/m0/s1.
What are the key properties of (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one?
(4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one has a molecular weight of 468.48 g/mol, XLogP of 6.95, 12 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-3-[(5E,9E,13E)-15-bromo-5,9,13-trimethylpentadeca-5,9,13-trienoyl]-4-propan-2-yl-1,3-oxazolidin-2-one is sourced from PubChem (CID 11851047), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).